Select Medical Holdings Corp SEM
We take great care to ensure that the data presented and summarized in this overview for SELECT MEDICAL HOLDINGS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SEM
View all-
Price T Rowe Associates Inc Baltimore, MD17.8MShares$271 Million0.04% of portfolio
-
Black Rock Inc. New York, NY16.9MShares$257 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$203 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.22MShares$64.3 Million0.02% of portfolio
-
State Street Corp Boston, MA4.2MShares$64 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.03MShares$61.5 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.02MShares$46 Million0.96% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$45.1 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA2.48MShares$37.8 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$26.1 Million0.02% of portfolio
Latest Institutional Activity in SEM
Top Purchases
Top Sells
About SEM
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Insider Transactions at SEM
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 05
2025
|
Parvinderjit S. Khanuja |
BUY
Open market or private purchase
|
Direct |
21,000
+24.39%
|
$315,000
$15.02 P/Share
|
May 04
2025
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
SELL
Payment of exercise price or tax liability
|
Direct |
1,330
-3.56%
|
$18,620
$14.26 P/Share
|
Apr 30
2025
|
David S Chernow CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,586
-3.16%
|
$406,548
$18.24 P/Share
|
Apr 30
2025
|
Michael E Tarvin EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
9,034
-2.07%
|
$162,612
$18.24 P/Share
|
Apr 29
2025
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+15.78%
|
-
|
Apr 29
2025
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
978
+0.34%
|
$17,604
$18.41 P/Share
|
Apr 28
2025
|
David S Chernow CEO |
SELL
Open market or private sale
|
Direct |
225,000
-23.95%
|
$4,050,000
$18.0 P/Share
|
Feb 12
2025
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
987
+0.34%
|
$17,766
$18.24 P/Share
|
Dec 04
2024
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
SELL
Open market or private sale
|
Direct |
4,989
-14.12%
|
$94,791
$19.95 P/Share
|
Nov 26
2024
|
Marilyn B Tavenner |
SELL
Open market or private sale
|
Direct |
32,000
-59.26%
|
$672,000
$21.09 P/Share
|
Nov 26
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
3,804,805
-100.0%
|
$72,291,295
$19.55 P/Share
|
Nov 05
2024
|
Michael E Tarvin EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
28,282
-6.08%
|
$1,046,434
$37.21 P/Share
|
Nov 05
2024
|
Thomas P Mullin CO-PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
36,742
-10.48%
|
$1,359,454
$37.21 P/Share
|
Nov 05
2024
|
John A. Saich EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
36,242
-5.22%
|
$1,340,954
$37.21 P/Share
|
Nov 05
2024
|
David S Chernow CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
70,704
-7.0%
|
$2,616,048
$37.21 P/Share
|
Nov 05
2024
|
Martin F Jackson EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
42,422
-3.25%
|
$1,569,614
$37.21 P/Share
|
Nov 05
2024
|
Michael F Malatesta CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
22,070
-11.47%
|
$816,590
$37.21 P/Share
|
Nov 05
2024
|
Brian R. Rusignuolo Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,690
-7.86%
|
$950,530
$37.21 P/Share
|
Nov 05
2024
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
SELL
Payment of exercise price or tax liability
|
Direct |
2,659
-7.0%
|
$98,383
$37.21 P/Share
|
Nov 05
2024
|
Christopher Weigl CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,746
-14.37%
|
$212,602
$37.21 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 11K shares |
---|---|
Open market or private purchase | 21K shares |
Bona fide gift | 220K shares |
Payment of exercise price or tax liability | 800K shares |
---|---|
Open market or private sale | 4.07M shares |
Bona fide gift | 220K shares |